Literature DB >> 33986595

Depression and Related Factors in Patients with Parkinson's Disease at High Altitude.

Yu Cao1, Gongfeng Li1, Jinsheng Xue2, Guijuan Zhang1, Sensen Gao1, Yuling Huang1, Aiqin Zhu1.   

Abstract

PURPOSE: Depression seems to aggravate progression of Parkinson's disease (PD). Hypoxia stress may be one of the pathogenic factors leading to PD. We investigated the characteristics of PD and factors related to Parkinson's disease depression (PDD) at high altitude (mean altitude ≥2300 m). PATIENTS AND METHODS: Totally 221 PD patients of three different nationalities (Han, Hui, and Tibetan) were recruited in a high-altitude hospital. Depression was present in 55.6% of them. Patient data were examined, including demographic information, medical history, disease duration and family history. Psychopathological characteristics and motor signs were assessed by the Hamilton Depression scale (HAMD) and scales for motor and non-motor symptoms in the Unified Parkinson's Disease Rating Scale (UPDRS). Progression of PD was evaluated by the modified Hoehn and Yahr (H-Y) staging system.
RESULTS: Mean age (47.1% men) was 68.25±13.67 years old, with disease duration of 4.18±5.13 years and median H-Y scores 2.07±0.97 points. Among three different nationalities, PD rate was 69.2% in Han nationals, 17.6% in Hui nationals and 13.1% in Tibetans of 221 PD patients. Compared with the non-depressed PD group, female, no-smoking and living alone rates, and dysphagia, pain, H-Y stage, ADL, UPDRS-I, UPDRS-III, HAMA, and PSQI scores were significantly increased in the PDD group, while MMSE scores were significantly decreased (P<0.05 or P<0.01). PD patients of Han and Hui nationalities had increased depression rates compared with Tibetan individuals (P<0.05). Compared with the mild depression group, the moderate and severe depression groups had significantly increased salivation, dysphagia, H-Y stage, UPDRS-I, UPDRS-III, HAMA, and PSQI scores (P<0.05 or P<0.01). Living alone rates and ADL scores were increased in the severe depression group (P<0.05). Logistic regression analysis showed that living alone (OR=19.833, 95% CI: 2.758-142.624, P<0.01), UPDRS-III score (OR=1.079, 95% CI: 1.009-1.153, P<0.05), and PSQI score (OR=1.538, 95% CI: 1.347-1.755, P<0.001) were risk factors for PDD. Male gender (OR=0.292, 95% CI: 0.112-0.763, P<0.05) was a protective factor in PDD.
CONCLUSION: PDD is associated with gender, ethnicity, loneliness, non-motor symptoms (NMSs), motor symptoms, and disease severity, and depression severity. Living alone, dyskinesia, and sleep disorder are risk factors for PDD at high altitude. A relative protection against depression was observed in the Tibetan population.
© 2021 Cao et al.

Entities:  

Keywords:  Parkinson’s disease; depression; high altitude; motor symptoms; non-motor symptoms

Year:  2021        PMID: 33986595      PMCID: PMC8110268          DOI: 10.2147/NDT.S300596

Source DB:  PubMed          Journal:  Neuropsychiatr Dis Treat        ISSN: 1176-6328            Impact factor:   2.570


  33 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  The effect of depression on motor function and disease severity of Parkinson's disease.

Authors:  Spiridon Papapetropoulos; John Ellul; Andreas A Argyriou; Elisabeth Chroni; Nicoletta P Lekka
Journal:  Clin Neurol Neurosurg       Date:  2005-09-16       Impact factor: 1.876

Review 3.  A systematic review of depression and mental illness preceding Parkinson's disease.

Authors:  L Ishihara; C Brayne
Journal:  Acta Neurol Scand       Date:  2006-04       Impact factor: 3.209

4.  International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Anthony H V Schapira; Fabrizio Stocchi; Kapil Sethi; Per Odin; Richard G Brown; William Koller; Paolo Barone; Graeme MacPhee; Linda Kelly; Martin Rabey; Doug MacMahon; Sue Thomas; William Ondo; David Rye; Alison Forbes; Susanne Tluk; Vandana Dhawan; Annette Bowron; Adrian J Williams; Charles W Olanow
Journal:  Mov Disord       Date:  2006-07       Impact factor: 10.338

5.  Relationship between sleep disorders and other non-motor symptoms in Parkinson's disease.

Authors:  Monica M Kurtis; Carmen Rodriguez-Blazquez; Pablo Martinez-Martin
Journal:  Parkinsonism Relat Disord       Date:  2013-08-15       Impact factor: 4.891

Review 6.  What a neurologist should know about depression in Parkinson's disease.

Authors:  Monique H M Timmer; Maria H C T van Beek; Bas R Bloem; Rianne A J Esselink
Journal:  Pract Neurol       Date:  2017-07-24

Review 7.  Prevalence and treatment of depression in Parkinson's disease.

Authors:  Connie Veazey; Sahinde Ozlem Erden Aki; Karon F Cook; Eugene C Lai; Mark E Kunik
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2005       Impact factor: 2.198

8.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

9.  Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort.

Authors:  Ryan J Uitti; Yasuhiko Baba; Zbigniew K Wszolek; D John Putzke
Journal:  Parkinsonism Relat Disord       Date:  2005-05       Impact factor: 4.891

Review 10.  Depressive symptoms in neurodegenerative diseases.

Authors:  Miquel Baquero; Nuria Martín
Journal:  World J Clin Cases       Date:  2015-08-16       Impact factor: 1.337

View more
  2 in total

Review 1.  The position of geochemical variables as causal co-factors of diseases of unknown aetiology.

Authors:  Theophilus C Davies
Journal:  SN Appl Sci       Date:  2022-07-27

2.  Naturalistic Study of Depression Associated with Parkinson's Disease in a National Public Neurological Referral Center in Mexico.

Authors:  Reinhard Janssen-Aguilar; Patricia Rojas; Elizabeth Ruiz-Sánchez; Mayela Rodriguez-Violante; Yessica M Alcántara-Flores; Daniel Crail-Meléndez; Amin Cervantes-Arriaga; Óscar Sánchez-Escandón; Ángel A Ruiz-Chow
Journal:  Brain Sci       Date:  2022-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.